Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges

Lookup NU author(s): Dr Diego Miranda Saavedra

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Inflammation is a fundamental response of the immune system whose successful termination involves the elimination of the invading pathogens, the resolution of inflammation and the repair of the local damaged tissue. In this context, the interleukin 10 (IL-10)-mediated anti-inflammatory response (AIR) represents an essential homeostatic mechanism that controls the degree and duration of inflammation. Here, we review recent work on the mechanistic characterization of the IL-10-mediated AIR on multiple levels: from the cataloguing of the in vivo genomic targets of STAT3 (the transcription factor downstream of IL-10) to the identification of specific co-factors that endow STAT3 with genomic-binding specificity, and how genomic and computational methods are being used to elucidate the regulatory mechanisms of this essential physiological response in macrophages.


Publication metadata

Author(s): Hutchins AP, Diez D, Miranda-Saavedra D

Publication type: Article

Publication status: Published

Journal: Briefings in Functional Genomics

Year: 2013

Volume: 12

Issue: 6

Pages: 489-498

Print publication date: 12/08/2013

ISSN (print): 2041-2649

ISSN (electronic): 2041-2657

URL: http://dx.doi.org/10.1093/bfgp/elt028

DOI: 10.1093/bfgp/elt028


Altmetrics

Altmetrics provided by Altmetric


Share